Chatterjee, M. Et Al. 2023. C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study. ALZHEIMERS & DEMENTIA , vol.19, no.11 , 4828-4840.

Chatterjee, M., Oezdemir, S., Kunadt, M., Koel-Simmelink, M., Boiten, W., Piepkorn, L., ... Pham, T. V.(2023). C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study. ALZHEIMERS & DEMENTIA , vol.19, no.11, 4828-4840.

Chatterjee, Madhurima Et Al. "C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study," ALZHEIMERS & DEMENTIA , vol.19, no.11, 4828-4840, 2023

Chatterjee, Madhurima Et Al. "C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study." ALZHEIMERS & DEMENTIA , vol.19, no.11, pp.4828-4840, 2023

Chatterjee, M. Et Al. (2023) . "C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study." ALZHEIMERS & DEMENTIA , vol.19, no.11, pp.4828-4840.

@article{article, author={Madhurima Chatterjee Et Al. }, title={C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study}, journal={ALZHEIMERS & DEMENTIA}, year=2023, pages={4828-4840} }